NECTIN2 and cancer: The checkpoint inhibitor TIGIT (T cell immunoreceptor with immunoglobulin and ITIM domain) plays a critical role in immune evasion of cancers via binding CD112 (PVRL2 or nectin-2), one of two TIGIT ligands [85].